Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 12, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc.
|
0
|
—
|
—
|
—
|
0
|
Apr 11
| |||||||
Alkermes Plc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eyepoint Pharmaceuticals, Inc.
| 22.59K |
$28.80 | -$430,358.40 | +12.04% | 210.24K |
Feb 9 - Feb 13
| |||||||
Eyepoint Pharmaceuticals, Inc.
| -35.00K |
$24.98 | -$874,199.64 | -20.53% | 135.44K |
Jan 23 - Jan 24
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 52.09K |
$20.40 | -$470,077.20 | +44.01% | 170.44K |
Jan 5 - Jan 6
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 170.56K |
Dec 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
| -20.00K |
$20.76 | -$415,200.00 | -10.50% | 170.56K |
Dec 4
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 10
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 11
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 37.53K |
—
|
—
| +24.53% | 190.56K |
Feb 9
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 6
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 12.47K |
—
|
—
| +9.05% | 150.28K |
Feb 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 13.72K |
—
|
—
| +11.05% | 137.81K |
Feb 21
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 17.53K |
—
|
—
| +16.45% | 124.1K |
Feb 9
| |||||||
Eyepoint Pharmaceuticals, Inc.
| -10.00K |
$20.15 | -$201,480.00 | -8.81% | 103.55K |
Nov 15
|
Scheduled
| ||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Aquestive Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 4.5K |
—
|
—
| +4.13% | 113.55K |
Jun 14
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 12.47K |
—
|
—
| +12.91% | 109.05K |
Feb 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 13.72K |
—
|
—
| +16.55% | 96.58K |
Feb 21
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 124.67K |
—
|
—
| +18.89% | 784.47K |
Jun 30
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 40K |
—
|
—
| +6.45% | 659.8K |
Jun 27
| |||||||
Aquestive Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 45K |
—
|
—
| +7.83% | 619.8K |
Jun 14
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 98K |
$1.06 | $104,027.00 | +20.55% | 574.8K |
Mar 10
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 28
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 137.17K |
—
|
—
| +40.39% | 476.8K |
Feb 21
| |||||||
Eyepoint Pharmaceuticals, Inc.
| -10.74K |
$2.11 | -$22,618.22 | -3.30% | 314.45K |
Oct 12
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 40K |
—
|
—
| +14.03% | 325.2K |
Jun 27
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 25
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 45K |
—
|
—
| +18.73% | 285.2K |
Jun 14
| |||||||
Aquestive Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 28.5K |
$1.76 | $50,245.50 | +13.46% | 240.2K |
Mar 29
| |||||||
Eyepoint Pharmaceuticals, Inc.
| 76.67K |
—
|
—
| +56.78% | 211.7K |
Oct 12
| |||||||
Aquestive Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 24
| |||||||
Aquestive Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eyepoint Pharmaceuticals, Inc.
| 40K |
—
|
—
| +42.09% | 135.03K |
Jun 27
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.